Ortho Regenerative Technologies said its chief scientific officer, Michael Buschmann, has been appointed as bioengineering chair, professor and eminent scholar (an award from Virginia’s Center for Innovative Technology) at George Mason University in Fairfax, VA.
Prior to his appointment, Dr. Buschmann established and led a multidisciplinary research program at Ecole Polytechnique in Montreal, focusing on the use of biomaterials to repair cartilage, meniscus and bone and to deliver plasmid DNA and small interfering RNA.
Dr. Buschmann has received numerous awards for his research, including the prestigious Canada Research Chair Tier 1 in 2001 and in 2008, the Melville Medal of the American Society of Mechanical Engineering in 1997 and Article of the Year for ASME Journal of Biomedical Engineering in 1996. He also has been the driving force behind several biotech start-up companies as founder or principal inventor.
In a statement, Ortho RTi executive chairman and CEO, Dr. Brent Norton, said Dr. Buschmann is a world-class researcher who has made fundamental and translational contributions to the fields of biomechanics, biomaterials, and nano-medicine.
“On a personal note, I look forward to continuing to work with him to bring products based on Ortho RTi’s proprietary biopolymer platform successfully to market,” he added.
